13 June 2019

Scancell issues new shares to Vulpes Life Sciences Fund

Scancell (AIM: SCLP), the developer of novel immunotherapies for the treatment of cancer, has raised £3.89m by the issue of new ordinary shares to Vulpes Life Sciences Fund.

Vulpes was founded in 2011 by Stephen Diggle, co-founder and former Managing Partner of Artradis Fund Management. Vulpes is designed to replicate a family office structure and enable outside co-investment in a range of strategies that seek to produce real capital appreciation and income by concentrating on a small number of compelling investment opportunities.

Co-founder Martin Diggle commented “Vulpes has been conducting scientific and commercial due diligence on Scancell for a considerable period of time. We have concluded the company's unique and innovative approach to fighting cancer is compelling and under-appreciated. At Vulpes we are always searching for overlooked companies that have the ability to make significant advances in medical science, with a view to supporting their development over the long term. We believe Scancell fulfil these criteria perfectly."

LGB is advising Scancell on the development of its investment proposition and its engagement with investors.

Recent Articles

27 June 2019

LGB advises RHEON LABS Ltd on oversubscribed £7 million equity capital raise

LGB Corporate Finance is pleased to announce that it has advised RHEON LABS Ltd on its oversubscribed £7 million Series A equity capital raise.  The transaction was achieved by way of a private placement.  Read more

Deals

19 June 2019

Issues of medium term notes (MTNs) arranged by LGB can now be settled in CREST

LGB has made arrangements for the settlement of an issue of MTNs by SRT Marine Systems plc through Euroclear’s CREST settlement system.

Read more

Deals

14 June 2019

Canadian IT services company CGI is acquiring SCISYS Group plc

SCISYS Group plc has received a cash offer from Canadian company CGI Inc. The offer price of 254.15p represents a 24.6% premium to yesterday’s closing price and values SCISYS at c£78.9m. Read more

Deals